MID1IP1-AS1: A Drug Target / Disease Biomarker (G100874211)

MID1IP1-AS1: A Drug Target / Disease Biomarker

MID1IP1-AS1, also known as MID1 or AS1, is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell signaling, specifically in the context of the insulin/IGF-1 signaling pathway. This pathway is involved in regulating various physiological processes in the body, including metabolism, growth, and reproduction.

MID1IP1-AS1 functions as a negative regulator of the insulin/IGF-1 signaling pathway. This means that when the body needs to increase insulin levels or stimulate the growth of a cell, MID1IP1-AS1 works to reverse the effects of the insulin/IGF-1 signaling pathway.

MID1IP1-AS1 is a 21-kDa protein that is expressed in various tissues throughout the body, including the brain, pancreas, and skeletal muscles. It is primarily localized to the endoplasmic reticulum (ER), a system of organelles that transports and stores proteins in the cell.

One of the unique features of MID1IP1-AS1 is its ability to interact with several different proteins, including the transcription factor ASXL1. This interaction between MID1IP1-AS1 and ASXL1 allows MID1IP1-AS1 to regulate the activity of ASXL1 and other transcription factors, ultimately controlling the expression of genes involved in cell signaling and metabolism.

MID1IP1-AS1 has also been shown to interact with the protein known as Pyruvatecarboxylase (PC). PC is a protein that is involved in the metabolism of pyruvate, a critical fuel for cellular energy metabolism. MID1IP1-AS1 has been shown to regulate the activity of PC, which in turn affects the levels of pyruvate in the cell.

In addition to its role in regulating cell signaling, MID1IP1-AS1 has also been shown to play a role in the development and progression of various diseases. For example, MID1IP1-AS1 has been shown to be involved in the development of cancer, particularly in the context of the insulin/IGF-1 signaling pathway.

MID1IP1-AS1 has also been shown to play a role in the regulation of cellular processes that are critical for the survival of the cell. For example, it has been shown to play a role in the regulation of cell apoptosis, a process by which cells undergo programmed cell death when they are no longer able to repair damage or continue to function.

Given its role in regulating cell signaling and the development and progression of various diseases, MID1IP1-AS1 is an attractive drug target or biomarker for researchers to study. There is ongoing research into the use of small molecules and other compounds to inhibit the activity of MID1IP1-AS1 and modulate its effects on cellular processes.

In conclusion, MID1IP1-AS1 is a protein that is involved in the regulation of cell signaling and has been shown to play a role in the development and progression of various diseases. Its potential as a drug target or biomarker makes it an important area of research for scientists to explore. Further studies are needed to fully understand the role of MID1IP1-AS1 in cellular processes and its potential as a therapeutic agent.

Protein Name: MID1IP1 Antisense RNA 1

The "MID1IP1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MID1IP1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MID2 | MIDEAS | MIDEAS-AS1 | MIDN | MIEF1 | MIEF2 | MIEN1 | MIER1 | MIER2 | MIER3 | MIF | MIF-AS1 | MIF4GD | MIGA1 | MIGA2 | MIIP | MILIP | MILR1 | MIMT1 | MINAR1 | MINAR2 | MINCR | MINDY1 | MINDY2 | MINDY2-DT | MINDY3 | MINDY4 | Minichromosome maintenance (MCM) 2-7 helicase complex | MINK1 | MINPP1 | MIOS | MIOX | MIP | MIPEP | MIPEPP3 | MIPOL1 | MIR1-1 | MIR1-1HG | MIR1-2 | MIR100 | MIR100HG | MIR101-1 | MIR101-2 | MIR10394 | MIR10396B | MIR10399 | MIR103A1 | MIR103A2 | MIR103B1 | MIR103B2 | MIR105-1 | MIR105-2 | MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238